Duobody-CD3xCD20 Induces Potent Anti-Tumor Activity in Malignant Lymph Node B Cells from Patients with DLBCL, FL and MCL Ex Vivo, Irrespective of Prior Treatment with CD20 Monoclonal Antibodies

Hilma J. Van der Horst; A. Vera de Jonge; Ida H. Hiemstra; Anne T. Gelderloos; Daniella Rai Berry; Nathalie J. Hijmering; Daphne de Jong; Martine E. D. Chamuleau; Sonja Zweegman; Esther C. W. Breij; Margaretha G. M. Roemer; Tuna Mutis

doi:https://doi.org/10.1182/blood-2019-125765

Duobody-CD3xCD20 Induces Potent Anti-Tumor Activity in Malignant Lymph Node B Cells from Patients with DLBCL, FL and MCL Ex Vivo, Irrespective of Prior Treatment with CD20 Monoclonal Antibodies

Hilma J. Van der Horst, A. Vera de Jonge, Ida H. Hiemstra, Anne T. Gelderloos, Daniella Rai Berry, Nathalie J. Hijmering, Daphne de Jong, Martine E. D. Chamuleau, Sonja Zweegman, Esther C. W. Breij, Margaretha G. M. Roemer, Tuna Mutis

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Journal	Blood
Volume	134
DOIs	https://doi.org/10.1182/blood-2019-125765
Publication status	Published - 13 Nov 2019

Access to Document

https://doi.org/10.1182/blood-2019-125765

Cite this

Van der Horst, H. J., de Jonge, A. V., Hiemstra, I. H., Gelderloos, A. T., Berry, D. R., Hijmering, N. J., de Jong, D., Chamuleau, M. E. D., Zweegman, S., Breij, E. C. W., Roemer, M. G. M., & Mutis, T. (2019). Duobody-CD3xCD20 Induces Potent Anti-Tumor Activity in Malignant Lymph Node B Cells from Patients with DLBCL, FL and MCL Ex Vivo, Irrespective of Prior Treatment with CD20 Monoclonal Antibodies. Blood, 134. https://doi.org/10.1182/blood-2019-125765

@article{50158d2573d64b9b95072ce283af7198,

title = "Duobody-CD3xCD20 Induces Potent Anti-Tumor Activity in Malignant Lymph Node B Cells from Patients with DLBCL, FL and MCL Ex Vivo, Irrespective of Prior Treatment with CD20 Monoclonal Antibodies",

author = "{Van der Horst}, {Hilma J.} and {de Jonge}, {A. Vera} and Hiemstra, {Ida H.} and Gelderloos, {Anne T.} and Berry, {Daniella Rai} and Hijmering, {Nathalie J.} and {de Jong}, Daphne and Chamuleau, {Martine E. D.} and Sonja Zweegman and Breij, {Esther C. W.} and Roemer, {Margaretha G. M.} and Tuna Mutis",

year = "2019",

month = nov,

day = "13",

doi = "https://doi.org/10.1182/blood-2019-125765",

language = "English",

volume = "134",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

}

Van der Horst, HJ , de Jonge, AV, Hiemstra, IH, Gelderloos, AT, Berry, DR, Hijmering, NJ, de Jong, D , Chamuleau, MED , Zweegman, S, Breij, ECW, Roemer, MGM & Mutis, T 2019, 'Duobody-CD3xCD20 Induces Potent Anti-Tumor Activity in Malignant Lymph Node B Cells from Patients with DLBCL, FL and MCL Ex Vivo, Irrespective of Prior Treatment with CD20 Monoclonal Antibodies', Blood, vol. 134. https://doi.org/10.1182/blood-2019-125765

Duobody-CD3xCD20 Induces Potent Anti-Tumor Activity in Malignant Lymph Node B Cells from Patients with DLBCL, FL and MCL Ex Vivo, Irrespective of Prior Treatment with CD20 Monoclonal Antibodies. / Van der Horst, Hilma J.; de Jonge, A. Vera; Hiemstra, Ida H. et al.
In: Blood, Vol. 134, 13.11.2019.

Research output: Contribution to journal › Meeting Abstract › Academic

TY - JOUR

T1 - Duobody-CD3xCD20 Induces Potent Anti-Tumor Activity in Malignant Lymph Node B Cells from Patients with DLBCL, FL and MCL Ex Vivo, Irrespective of Prior Treatment with CD20 Monoclonal Antibodies

AU - Van der Horst, Hilma J.

AU - de Jonge, A. Vera

AU - Hiemstra, Ida H.

AU - Gelderloos, Anne T.

AU - Berry, Daniella Rai

AU - Hijmering, Nathalie J.

AU - de Jong, Daphne

AU - Chamuleau, Martine E. D.

AU - Zweegman, Sonja

AU - Breij, Esther C. W.

AU - Roemer, Margaretha G. M.

AU - Mutis, Tuna

PY - 2019/11/13

Y1 - 2019/11/13

U2 - https://doi.org/10.1182/blood-2019-125765

DO - https://doi.org/10.1182/blood-2019-125765

M3 - Meeting Abstract

SN - 0006-4971

VL - 134

JO - Blood

JF - Blood

ER -